Sonus, Synt:em deal

Sonus Pharmaceuticals Inc. (SNUS), Bothell, Wash. Synt:em S.A., Nimes, France Business: Drug delivery, Neurology, Cancer SNUS will acquire Synt:em for an initial payment of about $10 million in stock...